Oral Abstract Session:
180. Late Breaker Symposium
Saturday, October 20, 2012: 10:30 AM-12:00 PM
Room: SDCC 24 ABC

Learning Objectives:


Target Audience: Academicians

Tracks: Epidemiology and Infection Control, Global ID, Investigative ID, HIV-STD-TB, Pediatric ID, Adult ID

Moderator:  David W. Kimberlin, MD, University of Alabama at Birmingham


10:30 AM
Efficacy and Safety of an Investigational Staphylococcus aureus Vaccine in Preventing Bacteremia and Deep Sternal Wound Infections after Cardiothoracic Surgery
Vance G Fowler, MD, MHS ; Keith Allen ; Edson Moreira ; Moustafa Moustafa ; Frank Isgro ; Helen Boucher, MD, FIDSA ; Ralph Corey ; Yehuda Carmeli, MD, MPH ; Robert Betts ; Jonathan Hartzel ; Tessie Mcneely ; Nicholas Kartsonis ; Dalya Guris ; Matthew Onorato ; Steven Smugar ; Mark Dinubile ; Ajoke Sobanjo-Ter Meulen

10:40 AM
Safety, Tolerability, and Immunogenicity of a novel 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: Results of a randomized, placebo controlled Phase 1 first-in-human study
Peter Richmond, MD ; Michael Nissen, MD ; Helen Marshall, MD ; Sepehr Shakib, MBBS ; Peter Hodsman, MBBS ; Qin Jiang, MS ; David Cooper, PhD ; Denise Rill, MSN ; James Baber, MBChB ; Joseph Eiden, MD ; Kathrin U. Jansen, PhD ; Annaliesa S. Anderson, PhD ; Edward Zito, PhD ; Douglas Girgenti, MD

10:50 AM
Preventing Staphylococcus aureus Surgical Site Infections: an Open-label, Randomized Trial of Nasal Mupirocin Ointment and Nasal Povidone-Iodine Solution
Michael S. Phillips, MD ; Joseph Bosco III, MD ; Andrew Rosenberg, MD ; Germaine Cuff, BSN, MPH ; Alycia Foti, BA ; Faith Skeete, RN ; Bo Shopsin, MD, PhD ; Robert Press, MD, PhD

11:00 AM
Microsporidiosis acquired through solid organ transplantation
Susan N. Hocevar, MD ; Christopher Paddock, MD, MPH ; Cedric W. Spak, MD ; Randall Rosenblatt, MD ; Hector Diaz-Luna, MD ; Isabel Castillo, RN, BSN ; Sergio Luna, RN ; Glen C. Friedman, MD ; Robyn A. Stoddard, DVM, PhD ; Rebekah V. Tiller, MPH ; Tammie Peterson, RN, MSN/MPH, CPTC ; Dianna M. Blau, DVM, PhD ; Rama Sriram ; Alexandre Da Silva, PhD ; Sherif R. Zaki, MD, PhD ; Govinda S. Visvesvara, PhD ; Matthew J. Kuehnert, MD

11:10 AM
A New National Healthcare Safety Network Definition to Identify Bloodstream Infections Related to Mucosal Barrier Injury: Results from a Multicenter Field Test
Isaac See, MD ; Martha Iwamoto, MD, MPH ; Katherine Allen-Bridson, RN, BSN, MScPH ; Teresa Horan, MPH ; Shelley Magill, MD, PhD ; Scott Fridkin, MD, FSHEA ; Nicola D. Thompson, PhD, MSc

11:20 AM

11:40 AM
Environmental Contamination of Pediatric Clinics With Bordetella pertussis
Elizabeth Barajas, MPH ; Stacey Hoferka, MPH, MSIS ; Rashmi Chugh, MD, MPH ; Kenneth Soyemi, MD, MPH

11:50 AM
Phase III randomized, double-blind, placebo-controlled trial of infliximab for intensification of primary therapy for Kawasaki disease
Adriana H. Tremoulet, MD, MAS ; Sonia Jain, PhD ; Preeti Jaggi, MD ; Susan Fernandez, MD ; Joan M. Pancheri, RN, BSN, CCRC ; Xiaoying Sun, MS ; John T. Kanegaye, MD ; John Kovalchin, MD ; Beth Printz, MD ; Octavio Ramilo, MD ; Jane C. Burns, MD

CME Credits:

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.